Up 17% in 2017 where to next for the Challenger Ltd share price?

The Challenger Ltd (ASX:CGF) share price has grown strongly in 2017, what does the next decade have in store?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Challenger Ltd (ASX: CGF) share price has grown by 17.6% since the start of 2017. Shareholders can be very happy with that, but I think there could be a lot more to come over the next several years.

Challenger is Australia's leading provider of annuities with a dominant market share. I think the business could grow strongly because of the following reasons:

Growth of distribution channels

Challenger gains access to more potential clients through its distribution network. The more channels it opens, the more annuities it can sell.

For example, in FY17 Colonial First State, CareSuper and LegalSuper all started offering Challenger annuities. In the first quarter of FY18 annuities will be sold through AMP Limited (ASX: AMP) and BT Investment Management Ltd (ASX: BTT).

Even though Challenger is already the market leader, there is a lot of untapped potential until all possible distribution channels have been opened.

Growth of target demographic

Every year that passes results in more hard-working individuals reaching retirement age. It's in this retirement period where Challenger's product is best suited.

An annuity can provide a retiree with guaranteed income, providing certainty for their capital and income.

The number of retirees is expected to substantially increase over the next two decades, greatly increasing Challenger's target market.

Financial advisers in their droves are suggesting their clients take up an annuity. Annuity sales grew by 53% in the quarter to 31 March 2017 compared to the prior corresponding period.

Partnership with Mitsui Sumitomo

Challenger has also created a relationship with Japanese business Mitsui Sumitomo, which is a large and established provider of Australian dollar (AUD) annuities for Japanese clients. Challenger is issuing 20-year AUD fixed rate annuities to Mitsui Sumitomo.

This is not a large part of sales (yet), but after only a few months the signs are positive that this could turn into a sizeable part of Challenger's business in the years to come.

Risks

Challenger will be susceptible to interest rate movements for a variety of reasons, so investors should be aware of the global rise of interest rates.

It's also exposed to any large market movements, such as in February 2016, because it's a financial stock with large funds under management.

The longer-term risk is the possibility that Challenger hasn't allocated enough money for future payments to retirees, but this can't be known for a number of years.

Foolish takeaway

Challenger is trading at 20x FY17'S estimated earnings with a grossed-up dividend yield of 3.62%. I think this is still a very reasonable price considering how much it is expected to grow in the decade ahead.

The amount of money entering the retirement phase is going to grow strongly over the coming years and I expect Challenger will grow strongly too.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited. The Motley Fool Australia owns shares of Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »